Co-founder & CEO, AI for predictable drug discovery and development at Deep Science Ventures | San Francisco, United States | Rezi

Co-founder & CEO, AI for predictable drug discovery and development at Deep Science Ventures

Co-founder & CEO, AI for predictable drug discovery and development

Deep Science Ventures · San Francisco, United States

3 weeks ago

Co-founder & CEO, AI for predictable drug discovery and development

Deep Science Ventures · San Francisco, United States

24 days ago
Resume preview

Impress employers and recruiters.
Choose from hundreds of resume examples.

Target Resume Now

About the Role

As Co-founder & CEO, you will lead the commercial and company-building efforts for an AI-driven drug discovery platform, guiding it from spin-out through multiple funding rounds and market establishment. You will work closely with technical co-founders to shape strategy, build the commercial engine, and scale the company.

Responsibilities

  • Shape strategy and positioning alongside the founding team.
  • Lead fundraising: run a competitive seed round and the path to Series A.
  • Build the commercial engine: partnerships, pilots and paying customers across pharma and biotech.
  • Build the company: hiring, story, board, grant and academic partnerships, and day-to-day operations.

Requirements

  • World-class expertise in a related technical field (AI, ML, therapeutics, etc.).
  • Either you've personally led a priced round, or your name and track record make one raisable.
  • US or UK based (or flexible on moving) and able to go full-time from spin-out.

Skills

  • AI
  • ML
  • Therapeutics
  • Commercial strategy
  • Fundraising
  • Business development
  • Company building
  • Team leadership
  • Investor relations
  • Partnership development

Location

  • UK-based
  • Hybrid

Work Type

  • Full-time
  • Hybrid

Experience Level

  • Experienced founder and operator
  • Scale a company from seed to Series A and beyond

Benefits

  • Meaningful co-founder equity, milestone-linked.
  • Access to proprietary venture-building tools, resources and processes.
  • Access to DSV's global network of investors, advisors and industrial partners.
  • A proven, working platform and a hard technical moat already in place.
  • Continuous post-spinout support including fundraising, commercial partnerships, recruitment and team-building.

About the Company

  • We're building the AI that fixes drug discovery: a scalable closed-loop agentic system that does the scientific reasoning and analysis end-to-end, generating traceable and verifiable predictions and decisions.
  • Deep Science Ventures (DSV) is on a mission to create a future in which both humans and the planet can thrive.
  • DSV is a leading deep-tech venture studio with a portfolio of 50+ science-led companies at a total valuation of ~$700m.
  • Operating across Pharmaceuticals, Climate, Agriculture, and Computation, we tackle the challenges defining these areas by taking a first-principles approach and partnering with leading institutions.